Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check6 days agoChange DetectedA site-wide notice says NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.4%

- Check13 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the software revision as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check20 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check41 days agoChange DetectedThe revision history now shows a new site revision v3.7.0 and removes the earlier v3.6.6 entry, updating the page's versioning trail. This is a metadata update to the page's history and does not affect the study data or functionality.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision label on the page updates from v3.6.5 to v3.6.6, indicating a new version of the study history page. This change is a metadata update and does not modify the actual study data or user-facing content.SummaryDifference0.1%

- Check76 days agoChange DetectedA dedicated version history section has been added to the study record history page, including labels like Study Record Versions and Record History. The UI now exposes actions such as Save and Download, and shows related views (Results Posted, Researcher View) to help users access and compare past submissions.SummaryDifference41%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.